ask="1.020"
ask_size="2000"
average_daily_volume="1391160"
bid="0.950"
bid_size="500"
book_value="0.606"
change="-0.010"
change_from_200_day_moving_average="-1.763"
change_from_50_day_moving_average="0.003"
change_from_52_week_high="-3.979"
change_From_52_week_low="0.451"
change_in_percent="-1.041%"
close="0.951"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="0.190"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.050"
high_52_weeks="4.930"
last_trade_date="1/17/2017"
last_trade_price="0.951"
last_trade_size="198"
last_trade_time="3:59pm"
low="0.950"
low_52_weeks="0.500"
market_capitalization="6.79M"
moving_average_200_day="2.714"
moving_average_50_day="0.948"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.330"
open="1.030"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-64.966%"
percent_change_from_50_day_moving_average="+0.265%"
percent_change_from_52_week_high="-80.710%"
percent_change_from_52_week_low="+90.200%"
previous_close="0.961"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.005"
price_per_book="1.586"
price_per_sales="2.685"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.580"
stock_exchange="NCM"
symbol="OPXA"
volume="650633"
weeks_range_52="0.500 - 4.930"
